Heghine Khachatryan on New Insights Into Bleeding Mechanisms in Acquired Hemophilia A
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, reposted from RPTH Journal on LinkedIn:
”New insights into bleeding mechanisms in acquired hemophilia A
A recent publication in Research and Practice in Thrombosis and Haemostasis (RPTH) highlights an often under-recognized contributor to bleeding severity in acquired hemophilia A (AHA): platelet function abnormalities.
The study demonstrates that beyond FVIII inhibitors, transient but clinically relevant platelet aggregation defects may be present during the acute phase of AHA and can improve in remission.
These findings help explain why bleeding severity does not always correlate with FVIII levels alone.
Why this matters clinically:
• Reinforces the concept that AHA is a multifactorial bleeding disorder
• Supports broader hemostatic assessment in complex bleeding cases
• Encourages individualized management beyond factor replacement
Congratulations to the authors for advancing our understanding of the interplay between coagulation and platelet function in rare bleeding disorders.”
Quoting RPTH Journal‘s post:
”Platelet dysfunction in acquired hemophilia A
Acquired hemophilia A (AHA) presents with a bleeding pattern distinct from inherited hemophilia, yet the contribution of platelet function abnormalities has remained poorly explored.
Bleeding patterns in AHA differ from inherited hemophilia and may involve platelet dysfunction
δ storage pool disease was identified in several patients with monoclonal gammopathy of undetermined significance
Acquired platelet abnormalities may contribute to bleeding severity in AHA
Read the full article here.”
Article: Platelet function abnormalities in acquired hemophilia A
Authors: Raffaella Rossio, Anna Lecchi, Silvia La Marca, Lidia Padovan, Roberta Gualtierotti, Cristina Novembrino, Chiara Suffritti, Sara Arcudi, Alessandro Ciavarella, Federico Boggio, Simona Maria Siboni, Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 10, 2026, 13:36Nirupama Yechoor: How Survivors of Stroke Define Spiritual Wellbeing in Recovery
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer
-
Mar 10, 2026, 12:54RishiRaj Sinha: Connecting Researchers Driving the Future of Stem Cell Science at ISSCR 2026
-
Mar 10, 2026, 12:48Kayley Pappas: Translating Cutting-Edge Science Into Better Care and Hope for Stroke Patients at Mayo Clinic